Toon Van Gorp

8.4k citations

219 papers · 4.8k indexed · 1 hit paper · h-index 35

Impact in

Reproductive Medicine top 0.1%
- Ovarian cancer diagnosis and treatment
- Endometriosis Research and Treatment
Obstetrics and Gynecology top 0.2%
- Endometrial and Cervical Cancer Treatments
- Uterine Myomas and Treatments

Papers in

Reproductive Medicine 141
- Ovarian cancer diagnosis and treatment 134
- Endometriosis Research and Treatment 18
Obstetrics and Gynecology 85
- Endometrial and Cervical Cancer Treatments 81
- Uterine Myomas and Treatments 14

Co-authors: Ignace Vergote Frédéric Amant Roy F.P.M. Kruitwagen Patrick Neven Isabelle Cadron Karin Leunen B.F.M. Slangen D. Timmerman
Journals: Gynecologic Oncology (34 papers)International Journal of Gynecological Cancer (34 papers)Journal of Clinical Oncology (26 papers)Annals of Oncology (14 papers)BMC Cancer (6 papers)
Partner nations: Belgium United States Italy

In The Last Decade

Toon Van Gorp

203 papers receiving 4.7k citations

Hit Papers

align trajectories log scale

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study 2023 · 220 citations

Peers

Countries citing papers authored by Toon Van Gorp

Since Specialization

Citations

This map shows the geographic impact of Toon Van Gorp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toon Van Gorp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toon Van Gorp more than expected).

Fields of papers citing papers by Toon Van Gorp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toon Van Gorp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toon Van Gorp. The network helps show where Toon Van Gorp may publish in the future.

Co-authors

The 25 scholars most cited alongside Toon Van Gorp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toon Van Gorp Line = papers co-authored together Toon Van Gorp links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	TroFuse-020/GOG-3101/ENGOT-Cx20: A Phase 3, Randomised, Active-Controlled, Open-Label, Multicentre Study Comparing Sacituzumab Tirumotecan Monotherapy Vs Treatment Of Physician’s Choice As Second-Line Treatment For Recurrent Or Metastatic Cervical Cancer International Journal of Gynecological Cancer ·Cafer Gülsever, Kristina Lindemann, Zhongqiu Lin, Shin Nishio, Ana Oaknin, Jean‐Emmanuel Kurtz, Giorgio Valabrega, M. Valeria Cáceres, Philipp Harter, Lucy Gilbert, Azmat Sadozye, А.В. Сафонов, Toon Van Gorp, Ingrid Boere, Christian Marth, Linda Duska, Bradley J. Monk, Mihail Luca, Cumhur Tekin, Mansoor Raza Mirza	2025	1
2	LBA45 ROSELLA (GOG3073, ENGOTov72, APGOT-OV10): Relacorilant + nab-paclitaxel in the subgroup of patients with platinum-resistant ovarian cancer (PROC) previously exposed to a PARP inhibitor Annals of Oncology ·سامية نايت عثمان, Tian Zhi-ha, John K. Chan, June‐Yong Lee, Mariana Scaranti, Leonardo Henrique da Silva, Carolyn Y. Muller, Linda Mileshkin, Toon Van Gorp, Lyndsay Willmott, Ana Santaballa Bertrán, Elizabeth Munro, М. А. Федорова, Barnet L. Rosenthal, 幹弥松下, Giuseppa Scandurra, Ròbert Póka, Sherstneva Lf, Birendra Kumar Yadav, Izabela Gołębiewska	2025	0
3	Single-cell profiling in ovarian germ cell and sex cord-stromal tumours British Journal of Cancer ·Chung‐Lin Chung, Anne‐Sophie Van Rompuy, G. Monnet, Gloria Marquina, José Luis Valdez-Medina, Siel Olbrecht, Tyler Kjorstad, Thaïs Baert, Toon Van Gorp, I. Vergote, Diether Lambrechts, Els Van Nieuwenhuysen	2025	0
4	Genetic Variants of Interleukin-8 and Interleukin-16 and Their Association with Cervical Cancer Risk Life ·Rafał Watrowski, Eva Schuster, Stephan Polterauer, Toon Van Gorp, Gerda Hofstetter, Michael B. Fischer, Sven� Mahner, Robert Zeillinger, Eva Obermayr	2025	0
5	Safety of antibody-drug conjugates in gynecologic cancers: current evidence and management approaches International Journal of Gynecological Cancer ·Sol Baek, Chung-Ping Liu, Stéphanie Lheureux, Toon Van Gorp, Ilaria Colombo, Ainhoa Madariaga	2025	0
6	A randomized, double-blind, phase II study of MK-4280A (coformulation of favezelimab and pembrolizumab) plus lenvatinib versus pembrolizumab plus lenvatinib among patients with previously-treated mismatch repair proficient advanced endometrial cancer Gynecologic Oncology ·Eugenia Girda, Vicky Makker, Christian Marth, Toon Van Gorp, Mansoor Raza Mirza, Sogomonian ZhM, Erin L. Ferguson, Roman Groisberg, Fan Jin, David M. O’Malley	2024	1
7	746P Phase III MIRASOL trial: Updated overall survival results of mirvetuximab soravtansine (MIRV) vs. investigator’s choice chemotherapy (ICC) in patients (pts) with platinum-resistant ovarian cancer (PROC) and high folate receptor-alpha (FRα) expression Annals of Oncology ·Marcelle Bernstein, I. V. Lobanok, ANTONI ANTONI, Yolanda García García, D GUILLOTVALLS, Rena Ervira Yuniastuti, А. П. Остапеня, 悠紀夫井原, José Ramón Morandeira García, Dagmara Klasa-Mazurkiewicz, Jasper Tromp, Teresa Irving, S. John Weroha, Chencho Tshering, 李泽春, James Stec, Toon Van Gorp	2024	4
8	Association of Four Interleukin-8 Polymorphisms (−251 A>T, +781 C>T, +1633 C>T, +2767 A>T) with Ovarian Cancer Risk: Focus on Menopausal Status and Endometriosis-Related Subtypes Biomedicines ·Rafał Watrowski, Eva Schuster, Gerda Hofstetter, Michael B. Fischer, Sven� Mahner, Toon Van Gorp, Stephan Polterauer, Robert Zeillinger, Eva Obermayr	2024	4
9	#1015 Mirvetuximab soravtansine demonstrates longer overall survival and progression-free survival by prior lines of therapy vs chemotherapy in platinum-resistant ovarian cancer and high folate receptor alpha expression in the MIRASOL trial Toon Van Gorp, Renaud Sabatier, Gottfried E. Konecny, J. B. Gordon, Sandro Pignata, Nicoletta Colombo, John W. Moroney, Lainie P. Martin, Jung‐Yun Lee, A. Roszak, Teresa Irving, Ingrid Boere, Olivier Trédan, Diane Provencher, Laura Farrelly, J.P. GAYARD, Yuemei Wang, Michael Method, Domenica Lorusso, Kathleen N. Moore	2023	2
10	LBA37 Atezolizumab (atezo) combined with platinum-based chemotherapy (CT) and maintenance niraparib for recurrent ovarian cancer (rOC) with a platinum-free interval (TFIp) >6 months: Primary analysis of the double-blind placebo (pbo)-controlled ENGOT-Ov41/GEICO 69-O/ANITA phase III trial Annals of Oncology ·Dyane Brito, M.J. Rubio Pérez, Florian Heitz, R D Christensen, Nicoletta Colombo, Toon Van Gorp, Ana Oaknin, Alexandra Léary, (unknown), Coriolan Lebreton, Farish Hg, Margarita Romeo, Andrés Redondo, M.P. Barretina Ginesta, José Alejandro Pérez Fidalgo, Ana Santaballa Bertrán, 季娇, Ilan Bruchim, Marta Bahlai, Frédèric Selle	2023	6
11	Association between hospital volume and outcomes in invasive ovarian cancer in Belgium: A population-based study European Journal of Cancer ·Isabelle Savoye, Geert Silversmit, Jolyce Bourgeois, Cindy De Gendt, Roos Leroy, Georges Amon, Sabine Stordeur, P. De Sutter, Frédéric Goffin, Mathieu Luyckx, 褚玉梅, Peter A. van Dam, Toon Van Gorp, Leen Verleye	2023	1
12	Relacorilant + Nab-Paclitaxel in Patients With Recurrent, Platinum-Resistant Ovarian Cancer: A Three-Arm, Randomized, Controlled, Open-Label Phase II Study Journal of Clinical Oncology ·Nicoletta Colombo, Toon Van Gorp, Ursula A. Matulonis, Ana Oaknin, Rachel N. Grisham, Gini F. Fleming, Alexander Olawaiye, Dorothy Nguyen, Andrew E. Greenstein, Joseph M. Custodio, Sherstneva Lf, Iulia Cristina Tudor, Domenica Lorusso	2023	16
13	2022-RA-1136-ESGO A single-cell map of rare ovarian cancer International Journal of Gynecological Cancer ·Chung‐Lin Chung, Pieter Busschaert, Siel Olbrecht, Liselore Loverix, Francesca Lodi, Thaïs Baert, Toon Van Gorp, Anne‐Sophie Van Rompuy, Ignace Vergote, Diether Lambrechts, Els Van Nieuwenhuysen	2022	2
14	2022-RA-884-ESGO Whole-body diffusion-weighted MRI (WB-DWI/MRI) for the prediction of resectable disease at the time of secondary cytoreductive surgery for relapsed epithelial ovarian cancer International Journal of Gynecological Cancer ·Kazutomo Iizuka, Vincent Vandecaveye, Raphaëla C. Dresen, Els Van Nieuwenhuysen, Thaïs Baert, Sileny Han, Patrick Neven, Patrick Berteloot, Frédéric Amant, Toon Van Gorp	2022	1
15	2022-RA-660-ESGO Characterization of extended treatment benefit from three phase 1 and 3 clinical trials examining patients with folate receptor alpha-positive recurrent ovarian cancer treated with single-agent mirvetuximab soravtansine International Journal of Gynecological Cancer ·Ana Oaknin, Domenica Lorusso, Amit M. Oza, Nicoletta Colombo, Toon Van Gorp, David M. O’Malley, Susana Banerjee, Conleth G. Murphy, Philipp Harter, Gottfried E. Konecny, Marie‐Christine Kaminsky, Michael Method, Jiuzhou Wang, Robert L. Coleman, Michael J. Birrer, Ursula A. Matulonis, Kathleen N. Moore	2022	1
16	2022-RA-959-ESGO Pelvic sentinel lymph nodedistribution; the final outcome of the Sentix trial (CEEGOG-CX01; ENGOT-CX2; NCT02494063) International Journal of Gynecological Cancer ·Roman Kocián, Christhardt Koehler, Suliya Phimmaha, Klára Benešová, Ignacio Zapardiel, Giampaolo Di Martino, Luc R.C.W. van Lonkhuijzen, Borek Sehnal, Octavio Arencibia, R. Della Puca, Fabio Martinelli, J Presl, Luboš Minář, 常一森下, Peter Kascak, Vania Rosal Guimarães Nascimento, S.S. Maltsev, Toon Van Gorp, Kristýna Němejcová, David Cibula	2022	1
17	Quality indicators for the management of epithelial ovarian cancer Isabelle Savoye, Cindy De Gendt, Jolyce Bourgeois, Georges Amon, Roos Leroy, Geert Silversmit, Sabine Stordeur, Liesbet Van Eycken, Cécile Colpaert, P. De Sutter, Hannelore Denys, Frédéric Goffin, K. Christopher Beard, Mathieu Luyckx, 褚玉梅, D. Timmerman, Peter A. van Dam, Toon Van Gorp, Geert Villeirs, Leen Verleye	2022	0
18	Association of a Combined Cancer Exhaustion Score with Circulating Tumor Cells and Outcome in Ovarian Cancer—A Study of the OVCAD Consortium Cancers ·Eva Obermayr, Elena Ioana Braicu, Stephan Polterauer, Liselore Loverix, Nicole Concin, Linn Woelber, Sven� Mahner, Jalid Sehouli, Toon Van Gorp, Ignace Vergote, Robert Zeillinger, Stefanie Aust	2021	4
19	tRNAGlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression Cancers ·Konstantina Panoutsopoulou, Tobias Dreyer, Julia Dorn, Eva Obermayr, Sven� Mahner, Toon Van Gorp, Elena Ioana Braicu, Robert Zeillinger, Viktor Magdolen, Margaritis Avgeris, Andreas Scorilas	2021	40
20	Assessment of protein biomarkers for preoperative differential diagnosis between benign and malignant ovarian tumors Gynecologic Oncology ·C. Landolfo, Erik Achten, Jolien Ceusters, Thaïs Baert, Wouter Froyman, Ruben Heremans, Adriaan Vanderstichele, Juan Manuel Montero Echeverri, Anaïs Van Hoylandt, Sandra Claes, Shaokang Zong, Anne‐Sophie Van Rompuy, Dominique Schols, Jaak Billen, Ben Van Calster, T. Bourne, Toon Van Gorp, Ignace Vergote, D. Timmerman, An Coosemans	2020	9

About Toon Van Gorp

Toon Van Gorp is a scholar working on Reproductive Medicine, Obstetrics and Gynecology, Oncology, Cancer Research and Surgery, having authored 219 papers that have together received 4.8k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (134 papers), Endometrial and Cervical Cancer Treatments (81 papers), Intraperitoneal and Appendiceal Malignancies (34 papers), PARP inhibition in cancer therapy (24 papers), Endometriosis Research and Treatment (18 papers), Cancer Genomics and Diagnostics (15 papers), Uterine Myomas and Treatments (14 papers) and Cervical Cancer and HPV Research (11 papers). The work is most often cited by research in Reproductive Medicine (2.9k citations), Obstetrics and Gynecology (1.8k citations), Geriatrics and Gerontology (203 citations), Oncology (1.1k citations) and Cancer Research (526 citations). Toon Van Gorp has collaborated with scholars based in Belgium, United States and Italy. Frequent co-authors include Ignace Vergote, Frédéric Amant, Roy F.P.M. Kruitwagen, Patrick Neven, Isabelle Cadron, Karin Leunen, B.F.M. Slangen, D. Timmerman, Steven W.M. Olde Damink and Iris J.G. Rutten. Their work appears in journals such as Gynecologic Oncology, International Journal of Gynecological Cancer, Journal of Clinical Oncology, Annals of Oncology and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact